Centene is trading at $74.47 (+10.36%) as Democrats’ control of both congressional chambers lifts expectations for a more favorable Medicaid and ACA policy outlook. - Reuters reported Centene shares rose over 8% in early trading. - Bernstein described the outcome as positive for Medicaid- and ACA-focused insurers, citing possible delays to Medicaid cuts and improved prospects for extending ACA subsidies. - The gain aligns with a broader healthcare rally; no distinct Centene-specific announcement explains the November 4 move.